// company-profile
Enliven Therapeutics, Inc.
ELVN// activity-summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $12.7M across 2 transactions.
// 90-day insight
Over the last 90 days, Enliven Therapeutics, Inc. insiders sold $12.7M across 2 transactions with no open-market purchases.
- Most active insider: Collins Helen Louise with 15 transactions totaling $694K.
- Largest single sale: $12.3M by ORBIMED ADVISORS LLC on Jun 15, 2026.
- 88% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bearish — sales outpace buys.
Institutional Ownership
Top 13F-HR holders of Enliven Therapeutics, Inc. as of 2026-03-31
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Collins Helen Louise | ELVN | Option Exercise10b5 | 5,000 | $0.00 | $0K |
| Jun 17, 2026 | Hohl Benjamin | ELVN | Option Exercise10b5 | 6,018 | $2.48 | $15K |
| Jun 17, 2026 | Hohl Benjamin | ELVN | Sale10b5 | 1,238 | $44.75 | $55K |
| Jun 17, 2026 | Hohl Benjamin | ELVN | Option Exercise10b5 | 6,018 | $0.00 | $0K |
| Jun 17, 2026 | Collins Helen Louise | ELVN | Sale10b5 | 1,268 | $42.83 | $54K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.